| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 5 |
| 1 | CARBOPLATIN | 4 |
| 2 | ALENDRONATE SODIUM | 3 |
| 3 | CYCLOBENZAPRINE | 3 |
| 4 | DULAGLUTIDE | 3 |
| 5 | EMPAGLIFLOZIN | 3 |
| 6 | FLUOROURACIL | 3 |
| 7 | FLUOROURACIL CREAM, 0.5% | 3 |
| 8 | GABAPENTIN | 3 |
| 9 | INSULIN GLARGINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MIFEPRISTONE | 3 | 0.0006 |
| 1 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL | 1 | 0.0006 |
| 2 | PASIREOTIDE | 1 | 0.0004 |
| 3 | PRUCALOPRIDE | 1 | 0.0004 |
| 4 | ETEPLIRSEN | 1 | 0.0004 |
| 5 | DANAZOL | 1 | 0.0004 |
| 6 | LANADELUMAB-FLYO | 1 | 0.0003 |
| 7 | C1 ESTERASE INHIBITOR RECOMBINANT | 2 | 0.0003 |
| 8 | FEXOFENADINE HCL | 1 | 0.0003 |
| 9 | GEMTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin Antagonist [EPC] | 3 | 0.0006 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 2 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 5 | Antisense Oligonucleotide [EPC] | 2 | 0.0002 |
| 6 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 7 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Bile Acid [EPC] | 1 | 0.0000 |